18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Phosphatases of regenerating liver (PRLs), the most oncogenic of all protein-tyrosine phosphatases (PTPs), play a critical role in metastatic progression of cancers. Recent findings established a new paradigm by uncovering that their association with magnesium transporters of the cyclin M (CNNM) family causes a rise in intracellular magnesium levels that promote oncogenic transformation. Recently, however, essential roles for regulation of the circadian rhythm and reproduction of the CNNM family have been highlighted. Here, we describe the crystal structure of PRL-1 in complex with the Bateman module of CNNM2 (CNNM2BAT), which consists of two cystathionine β-synthase (CBS) domains (IPR000664) and represents an intracellular regulatory module of the transporter. The structure reveals a heterotetrameric association, consisting of a disc-like homodimer of CNNM2BAT bound to two independent PRL-1 molecules, each one located at opposite tips of the disc. The structure highlights the key role played by Asp-558 at the extended loop of the CBS2 motif of CNNM2 in maintaining the association between the two proteins and proves that the interaction between CNNM2 and PRL-1 occurs via the catalytic domain of the phosphatase. Our data shed new light on the structural basis underlying the interaction between PRL phosphatases and CNNM transporters and provides a hypothesis about the molecular mechanism by which PRL-1, upon binding to CNNM2, might increase the intracellular concentration of Mg(2+) thereby contributing to tumor progression and metastasis. The availability of this structure sets the basis for the rational design of compounds modulating PRL-1 and CNNM2 activities.

          Related collections

          Author and article information

          Journal
          J. Biol. Chem.
          The Journal of biological chemistry
          American Society for Biochemistry & Molecular Biology (ASBMB)
          1083-351X
          0021-9258
          Jan 20 2017
          : 292
          : 3
          Affiliations
          [1 ] From the Structural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Technology Park of Bizkaia, 48160 Derio, Bizkaia, Spain.
          [2 ] the Rosalind and Morris Goodman Cancer Research Centre.
          [3 ] the Department of Pediatric Nephrology, Charité Universitäts Medizin, Berlin, 13353 Berlin, Germany.
          [4 ] the Berlin Institute of Health, Berlin, Germany.
          [5 ] the In-Cell NMR Laboratory, Department of NMR-supported Structural Biology, Leibniz Institute of Molecular Pharmacology (FMP Berlin), Robert-Rössle Strasse 10, 13125 Berlin, Germany.
          [6 ] Department of Biochemistry, and.
          [7 ] the Department of Physical Chemistry, Faculty of Sciences, University of Granada, Av. Fuentenueva s/n, 18071 Granada, Spain.
          [8 ] the Metabolomics Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Technology Park of Bizkaia, 48160 Derio, Bizkaia, Spain.
          [9 ] the Department of Biomedical Sciences, An-Najah National University, P. O. Box 7, Nablus, Palestinian Territory, and.
          [10 ] the Research Unit, Nuestra Señora de Candelaria University Hospital, 38010 Santa Cruz de Tenerife, Spain.
          [11 ] the Department of Pediatric Nephrology, Charité Universitäts Medizin, Berlin, 13353 Berlin, Germany, Dominik.Mueller@charite.de.
          [12 ] the Rosalind and Morris Goodman Cancer Research Centre, Michel.tremblay@mcgill.ca.
          [13 ] Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec H3A 1A3, Canada.
          [14 ] From the Structural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Technology Park of Bizkaia, 48160 Derio, Bizkaia, Spain, amartinez@cicbiogune.es.
          Article
          M116.759944
          10.1074/jbc.M116.759944
          5247653
          27899452
          18ec0873-1f71-4019-9c52-5470cc1d597f
          History

          PRL-1, CNNM2, CBS domain,cancer,cell proliferation,magnesium,phosphatase,transporter

          Comments

          Comment on this article